ADDEX THERAPEUTICS 2 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHFri, 06 Nov 2026 03:10:31 +0100https://images.finanzen.net/images/finanzen_net_neu.gifADDEX THERAPEUTICS 2 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netPress Release: Addex Therapeutics Announces Executive Management ChangesFri, 02 Oct 2026 06:59:41 +0200https://www.finanzen.net/nachricht/aktien/press-release-addex-therapeutics-announces-executive-management-changes-15964053-- Jean-Philippe Rocher Appointed Head of Pharmaceutical Development -- Mikhail Kalinichev, Head of Translational Science, Steps Down

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 2, 2026 - ]]>https://www.finanzen.net/nachricht/aktien/press-release-addex-therapeutics-announces-executive-management-changes-15964053Addex Therapeutics gewährte Anlegern Blick in die Bücher Tue, 29 Sep 2026 06:35:06 +0200https://www.finanzen.net/nachricht/aktien/addex-therapeutics-gewaehrte-anlegern-blick-in-die-buecher-15957377Addex Therapeutics hat am 28.09.2026 die Bilanz zum am 30.06.2026 abgelaufenen Quartal präsentiert.Der Verlust je Aktie belief sich auf 1,52 USD. Im Vorjahresquartal waren -2,900 USD je Aktie in den Büchern ...

]]>https://www.finanzen.net/nachricht/aktien/addex-therapeutics-gewaehrte-anlegern-blick-in-die-buecher-15957377Press Release: Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from IndiviorFri, 25 Sep 2026 06:59:42 +0200https://www.finanzen.net/nachricht/aktien/press-release-addex-regains-rights-to-gabab-positive-allosteric-modulator-portfolio-from-indivior-15952243Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 25, 2026 - https://www.globenewswire.com/Tracker?data=rUiAfdP3vDPo7cm0Kx06gFnpdLks3MybQ4dD9CyCL5xhuqrIbVD8gvCiVH2NCnBK5CPbgPmfGAa6kO_3reIqxWiZZRE3-NoEJE91i8Na_AI73oeCes_eajZFj8GzPDY6 ...

]]>https://www.finanzen.net/nachricht/aktien/press-release-addex-regains-rights-to-gabab-positive-allosteric-modulator-portfolio-from-indivior-15952243Press Release: ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027Wed, 26 Aug 2026 06:59:42 +0200https://www.finanzen.net/nachricht/aktien/press-release-addex-raises-usd-2-8-million-through-its-atm-agreement-and-extends-cash-runway-to-the-fourth-quarter-2027-15900623Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 26, 2026 - Addex Therapeutics https://www.globenewswire.com/Tracker?data=1FfvptEw-GJQVpO0t-5E1WafH1 ...

]]>https://www.finanzen.net/nachricht/aktien/press-release-addex-raises-usd-2-8-million-through-its-atm-agreement-and-extends-cash-runway-to-the-fourth-quarter-2027-15900623Press Release: Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and WakefulnessWed, 08 Jul 2026 06:59:41 +0200https://www.finanzen.net/nachricht/aktien/press-release-addex-announces-publication-of-research-highlighting-therapeutic-potential-of-mglu7-modulation-in-regulating-sleep-and-wakefulness-15786292Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - https://www.globenewswire.com/Tracker?data=U1CM-j6QBz3K9tXVd9ih2HDvz3778f4XyeTTgknl9IRtgQiFlmatYgwd-FQCtAJFricj2fIlG1g4L-hAPmqhGzb0N7d_SUHAnCjNeAQDtWNX_FOqviOeN3_cVi5WEGpp ...

]]>https://www.finanzen.net/nachricht/aktien/press-release-addex-announces-publication-of-research-highlighting-therapeutic-potential-of-mglu7-modulation-in-regulating-sleep-and-wakefulness-15786292Addex Therapeutics hat Bilanz für das abgelaufene Quartal gezogenSat, 27 Jun 2026 06:35:06 +0200https://www.finanzen.net/nachricht/aktien/addex-therapeutics-hat-bilanz-fuer-das-abgelaufene-quartal-gezogen-15768358Addex Therapeutics hat in der Finanzkonferenz zum Quartalsende am 25.06.2026 die Bücher zum vergangenen Jahresviertel geöffnet, das am 31.03.2026 abgelaufen war.Es wurde ein Verlust je Aktie in Höhe von ...

]]>https://www.finanzen.net/nachricht/aktien/addex-therapeutics-hat-bilanz-fuer-das-abgelaufene-quartal-gezogen-15768358